{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T07:21:00Z","timestamp":1794900060870,"version":"4.9.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-76544-x","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T09:57:16Z","timestamp":1786355836000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Immune niche composed of C1Q+ macrophages\/SFRP2+ CAFs\/CD8+ T cells drives immunotherapy response in HER2-positive gastric cancer"],"prefix":"10.1038","volume":"17","author":[{"given":"Yuhan","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lunbo","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0084-6810","authenticated-orcid":false,"given":"Yunfei","family":"Zhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghua","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shupeng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1429-0884","authenticated-orcid":false,"given":"Liang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"key":"76544_CR1","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/S2468-1253(19)30328-0","volume":"5","author":"A Etemadi","year":"2020","unstructured":"Etemadi, A. et al. The global, regional, and national burden of stomach cancer in 195 countries, 1990\u20132017: a systematic analysis for the Global Burden of Disease study 2017.  Lancet Gastroenterol. Hepatol. 5, 42\u201354 (2020).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"76544_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1158\/1055-9965.EPI-15-0578","volume":"25","author":"LA Torre","year":"2016","unstructured":"Torre, L. A., Siegel, R. L., Ward, E. M. & Jemal, A. Global cancer incidence and mortality rates and trends\u2014an update. Cancer Epidemiol. Biomark. Prev. 25, 16\u201327 (2016).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"76544_CR3","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"76544_CR4","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F. et al. Global Cancer Statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394\u2013424 (2018).","journal-title":"CA Cancer J. Clin."},{"key":"76544_CR5","doi-asserted-by":"publisher","first-page":"2408451","DOI":"10.1002\/advs.202408451","volume":"12","author":"Y Liao","year":"2025","unstructured":"Liao, Y. et al. Artificial intelligence for predicting HER2 status of gastric cancer based on whole-slide histopathology images: a retrospective multicenter study. Adv. Sci. 12, 2408451 (2025).","journal-title":"Adv. Sci."},{"key":"76544_CR6","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s10120-014-0402-y","volume":"18","author":"E Van Cutsem","year":"2015","unstructured":"Van Cutsem, E. et al. HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer. Gastric Cancer 18, 476\u2013484 (2015).","journal-title":"Gastric Cancer"},{"key":"76544_CR7","first-page":"264","volume":"71","author":"SS Joshi","year":"2021","unstructured":"Joshi, S. S. & Badgwell, B. D. Current treatment and recent progress in gastric cancer. CA Cancer J. Clin. 71, 264\u2013279 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"76544_CR8","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature 513, 202\u2013209 (2014).","DOI":"10.1038\/nature13480"},{"key":"76544_CR9","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/s41586-021-04161-3","volume":"600","author":"YY Janjigian","year":"2021","unstructured":"Janjigian, Y. Y. et al. The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer. Nature 600, 727\u2013730 (2021).","journal-title":"Nature"},{"key":"76544_CR10","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S1470-2045(21)00692-6","volume":"23","author":"Y Kang","year":"2022","unstructured":"Kang, Y. et al. Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial.  Lancet Oncol. 23, 234\u2013247 (2022).","journal-title":"Lancet Oncol."},{"key":"76544_CR11","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1001\/jamaoncol.2025.0522","volume":"11","author":"Z Peng","year":"2025","unstructured":"Peng, Z. et al. Atezolizumab and trastuzumab plus chemotherapy for ERBB2-positive locally advanced resectable gastric cancer: a randomized clinical trial. JAMA Oncol. 11, 619\u2013624 (2025).","journal-title":"JAMA Oncol."},{"key":"76544_CR12","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1016\/S0140-6736(23)02033-0","volume":"402","author":"YY Janjigian","year":"2023","unstructured":"Janjigian, Y. Y. et al. Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial. Lancet 402, 2197\u20132208 (2023).","journal-title":"Lancet"},{"key":"76544_CR13","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2018.1512942","volume":"8","author":"T Triulzi","year":"2018","unstructured":"Triulzi, T. et al. HER2 signaling regulates the tumor immune microenvironment and trastuzumab efficacy. Oncoimmunology 8, e1512942 (2018).","journal-title":"Oncoimmunology"},{"key":"76544_CR14","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1093\/cei\/uxac007","volume":"207","author":"S Cen","year":"2022","unstructured":"Cen, S. et al. Immune microenvironment characteristics and their implications for immune checkpoint inhibitor efficacy in HER2-overexpressing gastric cancer. Clin. Exp. Immunol. 207, 318\u2013328 (2022).","journal-title":"Clin. Exp. Immunol."},{"key":"76544_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-022-02734-7","volume":"23","author":"Z Li","year":"2022","unstructured":"Li, Z. & Zhou, X. BASS: multi-scale and multi-sample analysis enables accurate cell type clustering and spatial domain detection in spatial transcriptomic studies. Genome Biol. 23, 168 (2022).","journal-title":"Genome Biol."},{"key":"76544_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02064-1","volume":"23","author":"X Chu","year":"2024","unstructured":"Chu, X., Tian, Y. & Lv, C. Decoding the spatiotemporal heterogeneity of tumor-associated macrophages. Mol. Cancer 23, 150 (2024).","journal-title":"Mol. Cancer"},{"key":"76544_CR17","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.cell.2020.03.048","volume":"181","author":"L Zhang","year":"2020","unstructured":"Zhang, L. et al. Single-cell analyses inform mechanisms of myeloid-targeted therapies in colon cancer. Cell 181, 442\u2013459 (2020).","journal-title":"Cell"},{"key":"76544_CR18","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1073\/pnas.0610024104","volume":"104","author":"M Mirotsou","year":"2007","unstructured":"Mirotsou, M. et al. Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair. Proc. Natl. Acad. Sci. USA 104, 1643\u20131648 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"76544_CR19","doi-asserted-by":"publisher","first-page":"4809","DOI":"10.3390\/ijms26104809","volume":"26","author":"EJ Aller","year":"2025","unstructured":"Aller, E. J., Nair, H. B., Vadlamudi, R. K. & Viswanadhapalli, S. Significance of midkine signaling in women\u2019s cancers: novel biomarker and therapeutic target. Int. J. Mol. Sci. 26, 4809 (2025).","journal-title":"Int. J. Mol. Sci."},{"key":"76544_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-020-00248-0","volume":"9","author":"C Zhang","year":"2020","unstructured":"Zhang, C. et al. Galectin-9 promotes a suppressive microenvironment in human cancer by enhancing STING degradation. Oncogenesis 9, 65 (2020).","journal-title":"Oncogenesis"},{"key":"76544_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-025-00750-w","volume":"13","author":"W Zhang","year":"2025","unstructured":"Zhang, W. & Huang, X. Targeting cGAS-STING pathway for reprogramming tumor-associated macrophages to enhance anti-tumor immunotherapy. Biomark. Res. 13, 43 (2025).","journal-title":"Biomark. Res."},{"key":"76544_CR22","first-page":"45","volume":"21","author":"J Zhang","year":"2024","unstructured":"Zhang, J., Yu, S., Peng, Q., Wang, P. & Fang, L. Emerging mechanisms and implications of cGAS-STING signaling in cancer immunotherapy strategies. Cancer Biol. Med. 21, 45\u201364 (2024).","journal-title":"Cancer Biol. Med."},{"key":"76544_CR23","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1038\/s43587-024-00704-1","volume":"4","author":"S Meguro","year":"2024","unstructured":"Meguro, S. et al. Preexisting senescent fibroblasts in the aged bladder create a tumor-permissive niche through CXCL12 secretion. Nat. Aging 4, 1582\u20131597 (2024).","journal-title":"Nat. Aging"},{"key":"76544_CR24","doi-asserted-by":"publisher","first-page":"R448","DOI":"10.1016\/j.cub.2022.04.003","volume":"32","author":"M Varela-Eirin","year":"2022","unstructured":"Varela-Eirin, M. & Demaria, M. Cellular senescence. Curr. Biol. 32, R448\u2013R452 (2022).","journal-title":"Curr. Biol."},{"key":"76544_CR25","doi-asserted-by":"publisher","first-page":"o4577","DOI":"10.1126\/sciadv.abo4577","volume":"8","author":"X Liu","year":"2022","unstructured":"Liu, X. et al. SMAD4, activated by the TCR-triggered MEK\/ERK signaling pathway, critically regulates CD8(+) T cell cytotoxic function. Sci. Adv. 8, o4577 (2022).","journal-title":"Sci. Adv."},{"key":"76544_CR26","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/s41591-023-02758-x","volume":"30","author":"YL Verschoor","year":"2024","unstructured":"Verschoor, Y. L. et al. Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial. Nat. Med. 30, 519\u2013530 (2024).","journal-title":"Nat. Med."},{"key":"76544_CR27","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/S1470-2045(23)00541-7","volume":"25","author":"K Shitara","year":"2024","unstructured":"Shitara, K. et al. Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 study.  Lancet Oncol. 25, 212\u2013224 (2024).","journal-title":"Lancet Oncol."},{"key":"76544_CR28","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.3390\/cancers16071336","volume":"16","author":"MK Scheck","year":"2024","unstructured":"Scheck, M. K., Hofheinz, R. D. & Lorenzen, S. HER2-positive gastric cancer and antibody treatment: state of the art and future developments. Cancers 16, 1336 (2024).","journal-title":"Cancers"},{"key":"76544_CR29","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s10120-015-0502-3","volume":"19","author":"N Tominaga","year":"2016","unstructured":"Tominaga, N. et al. Five biopsy specimens from the proximal part of the tumor reliably determine HER2 protein expression status in gastric cancer. Gastric Cancer 19, 553\u2013560 (2016).","journal-title":"Gastric Cancer"},{"key":"76544_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38360-5","volume":"14","author":"C Sun","year":"2023","unstructured":"Sun, C. et al. Spatially resolved multi-omics highlights cell-specific metabolic remodeling and interactions in gastric cancer. Nat. Commun. 14, 2692 (2023).","journal-title":"Nat. Commun."},{"key":"76544_CR31","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1158\/2159-8290.CD-24-0605","volume":"15","author":"H Ma","year":"2025","unstructured":"Ma, H. et al. Spatially resolved tumor ecosystems and cell states in gastric adenocarcinoma progression and evolution. Cancer Discov. 15, 767\u2013792 (2025).","journal-title":"Cancer Discov."},{"key":"76544_CR32","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1158\/2159-8290.CD-21-0888","volume":"12","author":"R Kim","year":"2022","unstructured":"Kim, R. et al. Early tumor-immune microenvironmental remodeling and response to first-line fluoropyrimidine and platinum chemotherapy in advanced gastric cancer. Cancer Discov. 12, 984\u20131001 (2022).","journal-title":"Cancer Discov."},{"key":"76544_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28437-y","volume":"13","author":"J Cheong","year":"2022","unstructured":"Cheong, J. et al. Development and validation of a prognostic and predictive 32-gene signature for gastric cancer. Nat. Commun. 13, 774 (2022).","journal-title":"Nat. Commun."},{"key":"76544_CR34","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1158\/1078-0432.CCR-24-3528","volume":"31","author":"SH Lim","year":"2025","unstructured":"Lim, S. H. et al. Determinants of response to sequential pembrolizumab with trastuzumab plus platinum\/5-FU in HER2-positive gastric cancer: a phase II chemoimmunotherapy trial. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 31, 1476\u20131490 (2025).","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"76544_CR35","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1136\/gutjnl-2024-333617","volume":"74","author":"Y Li","year":"2025","unstructured":"Li, Y. et al. CAF-macrophage crosstalk in tumour microenvironments governs the response to immune checkpoint blockade in gastric cancer peritoneal metastases. Gut 74, 350 (2025).","journal-title":"Gut"},{"key":"76544_CR36","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.jhep.2023.01.011","volume":"78","author":"Y Liu","year":"2023","unstructured":"Liu, Y. et al. Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy. J. Hepatol. 78, 770\u2013782 (2023).","journal-title":"J. Hepatol."},{"key":"76544_CR37","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1053\/j.gastro.2024.08.007","volume":"167","author":"JJ Zhao","year":"2024","unstructured":"Zhao, J. J. et al. Spatially resolved niche and tumor microenvironmental alterations in gastric cancer peritoneal metastases. Gastroenterology 167, 1384\u20131398 (2024).","journal-title":"Gastroenterology"},{"key":"76544_CR38","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.ccell.2025.02.024","volume":"43","author":"Y Zhang","year":"2025","unstructured":"Zhang, Y. et al. PAI-1-driven SFRP2 high cancer-associated fibroblasts hijack the abscopal effect of radioimmunotherapy. Cancer Cell 43, 856\u2013874 (2025).","journal-title":"Cancer Cell"},{"key":"76544_CR39","doi-asserted-by":"publisher","first-page":"107628","DOI":"10.1016\/j.celrep.2020.107628","volume":"31","author":"S Davidson","year":"2020","unstructured":"Davidson, S. et al. Single-cell RNA sequencing reveals a dynamic stromal niche that supports tumor growth. Cell Rep. 31, 107628 (2020).","journal-title":"Cell Rep."},{"key":"76544_CR40","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1158\/2159-8290.CD-21-0683","volume":"12","author":"V Kumar","year":"2022","unstructured":"Kumar, V. et al. Single-cell Atlas of lineage states, tumor microenvironment, and subtype-specific expression programs in gastric cancer. Cancer Discov. 12, 670\u2013691 (2022).","journal-title":"Cancer Discov."},{"key":"76544_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6662","volume":"5","author":"K Shen","year":"2014","unstructured":"Shen, K. et al. Resolving cancer-stroma interfacial signalling and interventions with micropatterned tumour-stromal assays. Nat. Commun. 5, 5662 (2014).","journal-title":"Nat. Commun."},{"key":"76544_CR42","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1158\/0008-5472.CAN-22-1821","volume":"83","author":"S Ferri-Borgogno","year":"2023","unstructured":"Ferri-Borgogno, S. et al. Spatial transcriptomics depict ligand-receptor cross-talk heterogeneity at the tumor-stroma interface in long-term ovarian cancer survivors. Cancer Res. 83, 1503\u20131516 (2023).","journal-title":"Cancer Res."},{"key":"76544_CR43","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/j.ccell.2023.06.005","volume":"41","author":"R Wang","year":"2023","unstructured":"Wang, R. et al. Evolution of immune and stromal cell states and ecotypes during gastric adenocarcinoma progression. Cancer Cell 41, 1407\u20131426 (2023).","journal-title":"Cancer Cell"},{"key":"76544_CR44","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1093\/ajcp\/aqw206","volume":"146","author":"AN Bartley","year":"2016","unstructured":"Bartley, A. N. et al. HER2 testing and clinical decision making in gastroesophageal adenocarcinoma: guideline from the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology. Am. J. Clin. Pathol. 146, 647\u2013669 (2016).","journal-title":"Am. J. Clin. Pathol."},{"key":"76544_CR45","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289\u20131296 (2019).","journal-title":"Nat. Methods"},{"key":"76544_CR46","doi-asserted-by":"publisher","first-page":"D721","DOI":"10.1093\/nar\/gky900","volume":"47","author":"X Zhang","year":"2019","unstructured":"Zhang, X. et al. CellMarker: a manually curated resource of cell markers in human and mouse. Nucleic Acids Res. 47, D721\u2013D728 (2019).","journal-title":"Nucleic Acids Res."},{"key":"76544_CR47","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/nmeth.4402","volume":"14","author":"X Qiu","year":"2017","unstructured":"Qiu, X. et al. Reversed graph embedding resolves complex single-cell trajectories. Nat. Methods 14, 979\u2013982 (2017).","journal-title":"Nat. Methods"},{"key":"76544_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-018-4772-0","volume":"19","author":"K Street","year":"2018","unstructured":"Street, K. et al. Slingshot: cell lineage and pseudotime inference for single-cell transcriptomics. BMC Genom. 19, 477 (2018).","journal-title":"BMC Genom."},{"key":"76544_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin, S. et al. Inference and analysis of cell-cell communication using CellChat. Nat. Commun. 12, 1088 (2021).","journal-title":"Nat. Commun."},{"key":"76544_CR50","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nbt.3192","volume":"33","author":"R Satija","year":"2015","unstructured":"Satija, R., Farrell, J. A., Gennert, D., Schier, A. F. & Regev, A. Spatial reconstruction of single-cell gene expression data. Nat. Biotechnol. 33, 495\u2013502 (2015).","journal-title":"Nat. Biotechnol."},{"key":"76544_CR51","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1038\/s41587-022-01273-7","volume":"40","author":"Y Ma","year":"2022","unstructured":"Ma, Y. & Zhou, X. Spatially informed cell-type deconvolution for spatial transcriptomics. Nat. Biotechnol. 40, 1349\u20131359 (2022).","journal-title":"Nat. Biotechnol."},{"key":"76544_CR52","doi-asserted-by":"publisher","first-page":"e007441","DOI":"10.1136\/jitc-2023-007441","volume":"11","author":"S Zhang","year":"2023","unstructured":"Zhang, S. et al. C1q+ tumor-associated macrophages contribute to immunosuppression through fatty acid metabolic reprogramming in malignant pleural effusion. J. Immunother. Cancer 11, e007441 (2023).","journal-title":"J. Immunother. Cancer"},{"key":"76544_CR53","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.ccell.2018.01.011","volume":"33","author":"A Costa","year":"2018","unstructured":"Costa, A. et al. Fibroblast heterogeneity and immunosuppressive environment in human breast cancer. Cancer Cell 33, 463\u2013479 (2018).","journal-title":"Cancer Cell"},{"key":"76544_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06340-6","volume":"23","author":"Y Liao","year":"2025","unstructured":"Liao, Y. et al. N6-methyladenosine RNA modified BAIAP2L2 facilitates extracellular vesicles-mediated chemoresistance transmission in gastric cancer. J. Transl. Med. 23, 320 (2025).","journal-title":"J. Transl. Med."},{"key":"76544_CR55","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202521951","volume":"13","author":"Y Liao","year":"2026","unstructured":"Liao, Y. et al. PRELID1 and VDAC3 coordinate a senescence-like state in germinal center B cells to promote IL-7-driven antitumor immunity in colorectal cancer. Adv. Sci. 13, e21951 (2026).","journal-title":"Adv. Sci."},{"key":"76544_CR56","doi-asserted-by":"publisher","first-page":"111","DOI":"10.7150\/ijbs.118896","volume":"22","author":"Y Liao","year":"2026","unstructured":"Liao, Y. et al. A SENP7-SIRT1-IL-10 axis driven by DeSUMOylation promotes Breg differentiation and immune evasion in colorectal cancer. Int. J. Biol. Sci. 22, 111\u2013125 (2026).","journal-title":"Int. J. Biol. Sci."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76544-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76544-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76544-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:03:38Z","timestamp":1788865418000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76544-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["76544"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-76544-x","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]},"assertion":[{"value":"15 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"9574"}}